Artvigil 150 mg Tablets (Armodafinil)

Artvigil 150 mg Tablets: The Key Decision at a Glance

Artvigil tablets contain armodafinil, the R-enantiomer of modafinil, and that distinction matters when comparing once-daily wakefulness-promoting options. Armodafinil is generally taken once at the appropriate time for the condition being managed, although its effects and duration vary between individuals and it should not be expected to eliminate all sleepiness. We offer this medicine only as the 150 mg oral tablet, in pack sizes from 30 to 500 pills priced in Canadian dollars, so the practical choice for most shoppers comes down to matching pack size to the amount they intend to order rather than choosing between strengths.

What Is Artvigil and How Does It Differ From Other Wakefulness Options?

Artvigil is the catalogue name under which we supply armodafinil, a wakefulness-promoting agent classified under ATC code N06BA13. The tablet is taken orally and belongs to the same pharmacological family as modafinil, sold under brands such as Provigil, but armodafinil contains only the R-enantiomer rather than the R- and S-enantiomer mixture found in modafinil. The two medicines are dosed differently and should not be treated as milligram-for-milligram substitutes without professional guidance. We keep our Artvigil listing limited to a single 150 mg strength. Readers who want to compare modafinil directly can look at our Provigil listing.

Who May Consider Artvigil?

Armodafinil has an established role in improving wakefulness in adults with excessive sleepiness associated with narcolepsy, obstructive sleep apnea, or shift-work disorder. In obstructive sleep apnea, it addresses associated sleepiness rather than the underlying airway obstruction and does not replace treatments such as positive airway pressure. People evaluating Artvigil for one of these patterns may value a once-daily option that can be timed around a main waking or working period. Several groups, however, have good reason to avoid it or speak with a clinician first:

• People who are pregnant or trying to conceive, since armodafinil has been linked to a higher risk of major congenital malformations with pregnancy exposure.
• People relying on hormonal contraception, because armodafinil can reduce its effectiveness.
• Children and teenagers, for whom armodafinil has no established paediatric use.
• Anyone with known hypersensitivity to armodafinil, modafinil, or any tablet component.
• People with a history of serious rash, psychiatric symptoms, cardiovascular disease, or uncontrolled high blood pressure, who require an individual clinical assessment.
• Drivers or machine operators who have not yet learned how the medicine affects their alertness, judgment, and coordination.

Diabetes is not a product-specific contraindication, but that does not remove the need to review a person's overall health, medicines, and potential interactions before use. Common adverse effects can include headache, nausea, dizziness, and insomnia, while serious skin, allergic, cardiovascular, or psychiatric reactions require prompt medical attention.

How Armodafinil Works and What That Means for You

Armodafinil's exact wakefulness-promoting mechanism is not fully understood. Its known actions include binding to the dopamine transporter and inhibiting dopamine reuptake, which increases extracellular dopamine in parts of the brain involved in wakefulness. Other wake-regulating systems may also contribute, but the medicine should not be described as acting through one completely mapped pathway.

In practice, armodafinil may improve the ability to remain awake during the intended waking period, but response varies. It does not replace adequate sleep, treat the underlying obstruction in obstructive sleep apnea, or guarantee normal alertness. Some people may still experience residual sleepiness and should continue to avoid driving or hazardous work whenever their alertness is uncertain.

Building a Daily Routine Around Artvigil

For narcolepsy and obstructive sleep apnea, established adult regimens commonly use 150 mg or 250 mg once daily in the morning; the Artvigil product we offer contains 150 mg per tablet. For shift-work disorder, the established regimen is 150 mg taken approximately one hour before the work shift begins. The correct dose and timing depend on the individual, and tablets should be used only as directed by an appropriate healthcare professional.

Armodafinil can be taken with or without food. Food does not materially change overall absorption, but it can delay the time to peak concentration, especially after a substantial meal. Because the medicine can interfere with planned sleep, taking it later than intended may contribute to insomnia. Keeping the timing consistent makes it easier to assess benefit, adverse effects, and whether wakefulness still falls short at important times.

Strengths and Package Sizes We Offer

We list Artvigil exclusively as a 150 mg oral tablet, and we do not offer an extended-release version or another strength under this listing. Every package ordered from us therefore contains tablets of the same strength. The available quantities are:

• 30 pills
• 60 pills
• 100 pills
• 200 pills
• 300 pills
• 500 pills

Choosing between these counts depends on the quantity a customer intends to order and any professional advice they have received. Larger quantities may reduce how often a repeat order is needed, while smaller quantities limit the amount purchased at one time. All pricing is shown in Canadian dollars, making direct comparisons between the available quantities straightforward for Canadian shoppers.

What Should You Expect From the Timing and Effects?

Armodafinil is absorbed after an oral dose, with peak blood concentrations usually reached at about two hours under fasting conditions. Food may delay that peak by several hours, so a precise 30- to 60-minute onset should not be assumed. Its terminal half-life is approximately 15 hours, but that pharmacokinetic measure does not mean every person experiences the same degree of wakefulness for 15 hours.

Effects can extend through much of a waking or working period, which is why armodafinil is generally used once daily. The useful duration, strength of response, and impact on later sleep vary with dose timing, meals, individual metabolism, other medicines, and the cause of excessive sleepiness. People using it before a night shift should align the dose with the start of work while allowing for the possibility that it may make daytime sleep more difficult afterward.

Important Safety Priorities Before You Start

Because armodafinil affects the central nervous system and can cause serious reactions in a small number of people, a personal safety review is important before a first dose even though we do not require a medical consultation to process an order. The points below cover the main areas to check.

Stop taking the medicine and seek urgent medical advice if a rash, blistering, mouth sores, facial swelling, breathing difficulty, or another sign of a serious skin or allergic reaction develops. Mood changes, anxiety, agitation, hallucinations, suicidal thoughts, chest pain, palpitations, or a marked rise in blood pressure also warrant prompt assessment. Blood pressure and heart rate may need monitoring, particularly in people with cardiovascular risk factors.

Armodafinil should be avoided during pregnancy unless an appropriately qualified clinician determines that its use is justified. Human lactation evidence remains limited, so breastfeeding requires an individual benefit-risk discussion. It is not established for paediatric use, and older adults or people with severe liver impairment may require closer monitoring or a lower dose.

Interactions and Practical Precautions

Armodafinil affects liver enzymes involved in processing other medicines. A pharmacist, physician, or prescriber should review the complete medicine and supplement list because the clinically important interactions include more than one mechanism:

• Hormonal contraceptives, including pills, patches, rings, implants, injections, and hormonal intrauterine systems, may become less effective. An alternative or additional non-hormonal method is generally advised during treatment and for one month after the last dose.
• Cyclosporine and some other CYP3A4/5 substrates may have lower blood concentrations and may require clinical or concentration monitoring.
• Medicines processed through CYP2C19, including omeprazole, diazepam, and phenytoin, may reach higher concentrations and sometimes require monitoring or dose adjustment.
• Warfarin may require more frequent prothrombin time or INR monitoring when armodafinil is started or stopped.
• Other stimulants or wakefulness-promoting medicines can add to effects such as insomnia, anxiety, increased heart rate, or raised blood pressure.

Alcohol can impair judgment and coordination even if a person feels more awake, so armodafinil should never be used to offset alcohol-related impairment. Patients should also continue any primary treatment prescribed for an underlying sleep disorder and should not reduce or stop other therapy solely because wakefulness appears to improve.

Artvigil vs. Nuvigil: Which Fits Your Situation?

Artvigil and Nuvigil contain the same active ingredient, armodafinil, so the main distinctions involve brand, manufacturer, available tablet strengths, price, and supply. We offer Artvigil only as a 150 mg tablet. Nuvigil is an originator armodafinil brand that has been marketed in multiple tablet strengths, including 50 mg, 150 mg, 200 mg, and 250 mg, but it is not part of our current catalogue. Brand or strength changes should not be made on the assumption that every presentation is interchangeable without individual dosing guidance.

Customers specifically seeking Nuvigil will need to obtain it elsewhere. Those intending to order the 150 mg presentation can compare Artvigil's listed quantities and pricing through our current offer. In either case, the shared active ingredient means the same major contraindications, interactions, pregnancy concerns, and monitoring priorities remain relevant.

Ordering, Access, Delivery, and Receiving Your Package

Armodafinil is not currently authorized for human medicinal use in Canada; this is the supplied Canadian status of the active ingredient rather than a statement about one strength, brand, or package. Separately, our ordering policy does not require a prescription for us to accept an Artvigil order, although customers taking other medicines or managing a health condition should still consult an appropriate healthcare professional before use.

We have operated as an online pharmacy catalogue since 2017, and our support team is available 24/7 by email, online chat, or phone. A pharmacist is available to answer product questions before or after an order is placed. Ordering Artvigil follows our standard checkout process:

• Select one of the available 150 mg tablet quantities, from 30 to 500 pills.
• Review the price in Canadian dollars and complete checkout using our available payment options.
• Provide a complete delivery address, including the correct Canadian postal code where applicable.
• Track the order and contact our support team if a question arises.

Delivery timelines are estimates rather than guarantees because the arrival date depends on the destination and carrier schedule. Our support team can provide the available shipping and delivery information for a specific postal code. We pack orders discreetly, and support remains available after dispatch.

Making Your Decision

Choosing Artvigil means deciding whether a 150 mg once-daily armodafinil tablet fits the condition, schedule, safety considerations, and quantity involved. The key questions are whether the intended use is medically appropriate, whether another medicine or health condition creates a risk, whether the timing will interfere with planned sleep, and whether the selected package quantity is suitable. Armodafinil may improve wakefulness, but it does not replace sleep, primary treatment for obstructive sleep apnea, or professional assessment when excessive sleepiness remains uncontrolled.

Customers who understand those considerations and specifically want our available 150 mg presentation can choose from six package quantities. Readers comparing other wakefulness-promoting products can also visit our Stay-Awake section for related options.